Comparison of pregnancy outcome after adding oral or intramuscular progesterone to vaginal progesterone in frozen embryo transfer: A cross-sectional study

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 177

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJRM-22-10_001

تاریخ نمایه سازی: 21 آذر 1403

چکیده مقاله:

Background: Currently, frozen embryo transfers (FET) account for ۴۱% of all embryo transfer cycles. Vaginal progesterone preparations have become the leading choice for luteal phase support due to their convenient application; however, using only vaginal progesterone during FET cycles results in a lower ongoing pregnancy rate. Objective: This study aimed to investigate whether replacing intramuscular (IM) progesterone with oral dydrogesterone in FET cycles affects pregnancy outcomes or not. Materials and Methods: In this cross-sectional study, pregnancy outcomes were analyzed in women who underwent cleavage stage FET during an endometrial preparation cycle using hormone replacement therapy at Yazd Reproductive Sciences Institute, Yazd, Iran, between April ۲۰۲۳ and November ۲۰۲۳. The study examined ۲ groups based on a luteal phase support regimen: the dydrogesterone group, which received vaginal progesterone and oral dydrogesterone, and the IM progesterone group, which received vaginal progesterone and IM progesterone. Data were extracted from patient files to compare outcomes between the ۲ groups. Results: A total of ۹۶۰ cycles meeting the inclusion criteria were analyzed, with ۲۹۲ women in the dydrogesterone group and ۶۶۸ women in the IM progesterone group, and pregnancy outcomes were compared between the ۲ groups. The chemical pregnancy rates (۲۸.۴% vs. ۲۹.۹%, p = ۰.۶۳۶), clinical pregnancy rates (۲۵.۳% vs. ۲۶.۹%, p = ۰.۶۰۴), and ongoing pregnancy rates (۲۱.۹% vs. ۲۳.۸%, p = ۰.۵۲۵) were lower and miscarriage rates (۱۴.۷% vs. ۱۱.۷%, p = ۰.۲۱۰) were higher in dydrogesterone group compared to IM progesterone group, although this difference was not statistically significant. Conclusion: Based on the ease of use and similar pregnancy outcomes of oral dydrogesterone, it can potentially replace the daily injections of IM progesterone.

نویسندگان

Sahereh Arabian

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Maryam Eftekhar

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Saeideh Dashti

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Nahid Homayoon

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Elham Nikfarjam

Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara ...
  • Duijkers I, Klingmann I, Prinz R, Wargenau M, Hrafnsdottir S, ...
  • Dashti S, Eftekhar M. Luteal-phase support in assisted reproductive technology: ...
  • Rao KA, Rao VA, Devi R. Principles and practice of ...
  • Coombes Z, Plant K, Freire C, Basit AW, Butler P, ...
  • Piette PC. The pharmacodynamics and safety of progesterone. Best Pract ...
  • Di Renzo GC, Tosto V, Tsibizova V. Progesterone: History, facts, ...
  • Griesinger G, Tournaye H, Macklon N, Petraglia F, Arck P, ...
  • Jalaliani S, Davar R, Akbarzadeh F, Emami F, Eftekhar M. ...
  • Mohammed A, Woad KJ, Mann GE, Craigon J, Raine-Fenning N, ...
  • Pabuçcu EG, Pabuçcu R, Evliyaoglu Ozdegirmenci O, Bostancı Durmus A, ...
  • Devine K, Richter KS, Widra EA, McKeeby JL. Vitrified blastocyst ...
  • Devine K, Richter KS, Jahandideh S, Widra EA, McKeeby JL. ...
  • Homayoon N, Arabian S, Mangoli E, Bayati F, Eftekhar M. ...
  • Child T, Leonard SA, Evans JS, Lass A. Systematic review ...
  • Simon V, Robin G, Keller L, Ternynck C, Jonard S, ...
  • Ikechebelu JI, Dim CC, Eleje GU, Joe-Ikechebelu N, Okpala BC, ...
  • Vidal A, Dhakal C, Werth N, Weiss JM, Lehnick D, ...
  • Salehpour S, Tamimi M, Saharkhiz N. Comparison of oral dydrogesterone ...
  • Simon JA, Robinson DE, Andrews MC, Hildebrand III JR, Rocci ...
  • Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase ...
  • Yang D-Z, Griesinger G, Wang W, Gong F, Liang X, ...
  • Bachar G, Haskia C, Fainaru O. Comparable outcomes using oral ...
  • نمایش کامل مراجع